Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Agata Hanna Bryk-Wiązania in
Google Scholar
PubMed
Search for other papers by Mari Minasyan in
Google Scholar
PubMed
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland
Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed
platelets, increased thrombin generation, elevated concentrations of fibrinogen and fibrinolysis inhibitors, and compensatory elevation of endogenous anticoagulants such as protein C and protein S ( 3 , 4 , 5 , 6 ). However, no linear relationship with
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Mette Bøgehave in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark, Odense, Denmark
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Jørgen Brodersen Gram in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Else-Marie Bladbjerg in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Johannes Jakobsen Sidelmann in
Google Scholar
PubMed
). CVD can be caused by atherosclerosis and thrombosis, and alterations in the coagulation system ( Fig. 1 ) contribute significantly to the pathogenesis of thrombosis. It remains unclear whether TRT induces a pro- or anticoagulant state. Reportedly
Search for other papers by Eng-Loon Tng in
Google Scholar
PubMed
Search for other papers by Yee Sian Tiong in
Google Scholar
PubMed
Search for other papers by Aye Thida Aung in
Google Scholar
PubMed
Search for other papers by Nicole Ya Yuan Chong in
Google Scholar
PubMed
Search for other papers by Zhemin Wang in
Google Scholar
PubMed
). However, warfarin and direct oral anticoagulants (DOACs) did not prevent stroke in two retrospective cohort studies ( 6 , 15 ). There are no systematic reviews or Cochrane reviews on this topic. Materials and methods The primary objective is the
Search for other papers by M Cherenko in
Google Scholar
PubMed
Search for other papers by N M Appelman-Dijkstra in
Google Scholar
PubMed
Search for other papers by A L Priego Zurita in
Google Scholar
PubMed
Search for other papers by N R Biermasz in
Google Scholar
PubMed
Search for other papers by O M Dekkers in
Google Scholar
PubMed
Search for other papers by F A Klok in
Google Scholar
PubMed
Search for other papers by N Reisch in
Google Scholar
PubMed
Search for other papers by A Aulinas in
Google Scholar
PubMed
Search for other papers by B Biagetti in
Google Scholar
PubMed
Search for other papers by S Cannavo in
Google Scholar
PubMed
Search for other papers by L Canu in
Google Scholar
PubMed
Search for other papers by M Detomas in
Google Scholar
PubMed
Search for other papers by F Devuyst in
Google Scholar
PubMed
Search for other papers by H Falhammar in
Google Scholar
PubMed
Search for other papers by R A Feelders in
Google Scholar
PubMed
Search for other papers by F Ferrau in
Google Scholar
PubMed
Search for other papers by F Gatto in
Google Scholar
PubMed
Search for other papers by C Grasselli in
Google Scholar
PubMed
Search for other papers by P van Houten in
Google Scholar
PubMed
Search for other papers by C Hoybye in
Google Scholar
PubMed
Search for other papers by A M Isidori in
Google Scholar
PubMed
Search for other papers by A Kyrilli in
Google Scholar
PubMed
Search for other papers by P Loli in
Google Scholar
PubMed
Search for other papers by D Maiter in
Google Scholar
PubMed
Search for other papers by E Nowak in
Google Scholar
PubMed
Search for other papers by R Pivonello in
Google Scholar
PubMed
Search for other papers by O Ragnarsson in
Google Scholar
PubMed
Search for other papers by R V Steenaard in
Google Scholar
PubMed
Search for other papers by N Unger in
Google Scholar
PubMed
Search for other papers by A van de Ven in
Google Scholar
PubMed
Search for other papers by S M Webb in
Google Scholar
PubMed
Search for other papers by D Yeste in
Google Scholar
PubMed
University of Glasgow, Office for Rare Conditions, Glasgow, UK
University of Glasgow, Developmental Endocrinology Research Group, Royal Hospital for Children, Glasgow, UK
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Search for other papers by A M Pereira in
Google Scholar
PubMed
concentrations ( 11 , 12 ), impaired fibrinolysis ( 4 ) and endothelial dysfunction ( 13 ). Changes in pro- and anticoagulant factors may persist after successful surgery or medical therapy for at least several months ( 14 , 15 ). Given the lack of evidence
Search for other papers by Eva Novoa in
Google Scholar
PubMed
Search for other papers by Marcel Gärtner in
Google Scholar
PubMed
Search for other papers by Christoph Henzen in
Google Scholar
PubMed
, infections, particularly middle ear infections, trauma or surgery, and possible drug interactions with dexamethasone (i.e. antidiabetic, anticonvulsants, oral anticoagulants, antihypertensives, antidepressants, NSAID, and statins), as well as blood glucose
Search for other papers by Ali Abbara in
Google Scholar
PubMed
Search for other papers by Sophie Clarke in
Google Scholar
PubMed
Search for other papers by Pei Chia Eng in
Google Scholar
PubMed
Search for other papers by James Milburn in
Google Scholar
PubMed
Search for other papers by Devavrata Joshi in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Alexander N Comninos in
Google Scholar
PubMed
Search for other papers by Rozana Ramli in
Google Scholar
PubMed
Search for other papers by Amrish Mehta in
Google Scholar
PubMed
Search for other papers by Brynmor Jones in
Google Scholar
PubMed
Search for other papers by Florian Wernig in
Google Scholar
PubMed
Search for other papers by Ramesh Nair in
Google Scholar
PubMed
Search for other papers by Nigel Mendoza in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Amir H Sam in
Google Scholar
PubMed
Search for other papers by Emma Hatfield in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Waljit S Dhillo in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, London, UK
Search for other papers by Niamh M Martin in
Google Scholar
PubMed
patients, pituitary apoplexy was precipitated following administration of antiplatelet/anticoagulant therapy for acute coronary syndrome. Table 1 Demographics, predisposing factors and adenoma type in the patients who present with pituitary apoplexy
Search for other papers by Marc Blondon in
Google Scholar
PubMed
Search for other papers by Emmanuel Biver in
Google Scholar
PubMed
Search for other papers by Olivia Braillard in
Google Scholar
PubMed
Search for other papers by Marc Righini in
Google Scholar
PubMed
Search for other papers by Pierre Fontana in
Google Scholar
PubMed
Search for other papers by Alessandro Casini in
Google Scholar
PubMed
anticoagulant or calcium/vitamin D supplements, an active cancer (diagnosed within 5 years or treated within 2 years), renal insufficiency (eGFR <30 mL/min), a primary hyperparathyroidism, any malabsorption disease, an active inflammatory disease, a recent
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jesper Krogh in
Google Scholar
PubMed
Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Peter Plomgaard in
Google Scholar
PubMed
Department of Clinical Biochemistry, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Ruth Frikke-Schmidt in
Google Scholar
PubMed
Search for other papers by Sten Velschow in
Google Scholar
PubMed
Department of Pediatrics, Copenhagen University Hospital - Herlev & Gentofte, Copenhagen, Denmark
Search for other papers by Jesper Johannesen in
Google Scholar
PubMed
Search for other papers by Linda Maria Hilsted in
Google Scholar
PubMed
Search for other papers by Malene Schrøder in
Google Scholar
PubMed
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
could be mended by increasing the flow of anticoagulants in future trials. Importantly, no serious adverse events occurred, and blood sampling before and after insertion suggested a clinically non-significant fall in thrombocytes but otherwise no
Search for other papers by Hong Wang in
Google Scholar
PubMed
Search for other papers by Jie Cao in
Google Scholar
PubMed
Search for other papers by Jian-bin Su in
Google Scholar
PubMed
Search for other papers by Xue-qin Wang in
Google Scholar
PubMed
Search for other papers by Dong-mei Zhang in
Google Scholar
PubMed
Search for other papers by Xiao-hua Wang in
Google Scholar
PubMed
these insulin resistance indices were independently associated with poor outcomes of cardiovascular disease (CVD) and acute ischemic stroke ( 6 , 7 ). Antithrombin 3 (AT3), one of the most important natural anticoagulants, plays a key role in
Search for other papers by Shenghe Luo in
Google Scholar
PubMed
Department of Cardiology, Yanbian University Hospital, Yanji, China
Search for other papers by Yunhui Zuo in
Google Scholar
PubMed
Search for other papers by Xiaotian Cui in
Google Scholar
PubMed
Search for other papers by Meiping Zhang in
Google Scholar
PubMed
Search for other papers by Honghua Jin in
Google Scholar
PubMed
Search for other papers by Lan Hong in
Google Scholar
PubMed
the ET tubes containing anticoagulants (10 μL EDTA and 20 μL aprotinin per ET anticoagulant tube) for subsequent ANP assays, the heart was immediately removed at −80°C for subsequent experiments. Determination of ANP content ANP concentrations